Emerging biological functions of the Vaccinia-related Kinase (VRK) family

Histology and Histopathology

Volumn 24, Issue 6, 2009, Pages 749-759

  Klerkx, Elke P F ^a   Lazo, Pedro A ^b   Askjaer, Peter ^a  

^a UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^b CSIC   (Spain)

Author keywords

Cell signaling; Nuclear envelope; Protein kinase; Transcription factor; VRK

Indexed keywords

VACCINIA VIRUS;

PROTEIN SERINE THREONINE KINASE;

ANIMAL; HUMAN; PHYLOGENY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; PHYLOGENY; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 67650225155     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Aihara H., Nakagawa T., Yasui K., Ohta T., Hirose S., Dhomae N., Takio K., Kaneko M., Takeshima Y., Muramatsu M. and Ito T. (2004). Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in the early Drosophila embryo. Genes Dev. 18, 877-888.
2. Amati B., Alevizopoulos K. and Vlach J. (1998). Myc and the cell cycle. Front. Biosci. 3, 250-268.
3. Ashcroft M. and Vousden K.H. (1999). Regulation of p53 stability. Oncogene 18, 7637-7643.
4. Barcia R., López-Borges S., Vega F.M. and Lazo P.A. (2002). Kinetic properties of p53 phosphorylation by the human vaccinia-related kinase 1. Arch. Biochem. Biophys. 399, 1-5.
5. Bargonetti J. and Manfredi J.J. (2002). Multiple roles of the tumor suppressor p53. Curr. Opin. Oncol. 14, 86-91.
6. Berger S.L. (2007). The complex language of chromatin regulation during transcription. Nature 447, 407-412.
7. Blanco S., Klimcakova L., Vega F.M. and Lazo PA. (2006). The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines. FEBS J. 273, 2487-2504.
8. Blanco S., Santos C. and Lazo P.A. (2007). Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1. Mol. Cell. Biol. 27, 7273-7283.
9. Blanco S., Sanz-García M., Santos C.R. and Lazo P.A. (2008). Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein. PLoS ONE 3, e1660.
10. Bos J.L. (1989). Ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689.
11. Boyle K.A. and Traktman P. (2004). Members of a novel family of mammalian protein kinases complement the DNA-negative phenotype of a vaccinia virus ts mutant defective in the B1 kinase. J. Virol. 78, 1992-2005.
12. Brittle A.L., Nanba Y., Ito T. and Ohkura H. (2007). Concerted action of Aurora B, Polo and NHK-1 kinases in centromere-specific histone 2A phosphorylation. Exp. Cell. Res. 313, 2780-2785.
13. Caenepeel S., Charydczak G., Sudarsanam S., Hunter T. and Manning G. (2004). The mouse kinome: discovery and comparative genomics of all mouse protein kinases. Proc. Natl. Acad. Sci. USA 101, 11707-11712.
14. Chang L. and Karin M. (2001). Mammalian MAP kinase signalling cascades. Nature 410, 37-40.
15. Chueng W.L., Ajiro K., Samejima K., Kloc M., Chueng P., Mizzen C.A., Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C. and Allis C.D. (2003). Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113, 507-517.
16. Clarke P.R. and Zhang C. (2008). Spatial and temporal coordination of mitosis by Ran GTPase. Nat. Rev. Mol. Cell Biol. 9, 464-477.
17. Cohen P. and Frame S. (2001). The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769-776.
18. Cullen C.F., Brittle A.L., Ito T. and Ohkura H. (2005). The conserved kinase NHK-1 is essential for mitotic progression and unifying acentrosomal meiotic spindles in Drosophila melanogaster. J. Cell Biol. 171, 593-602.
19. De Souza C.P., Osmani A.H., Wu L.P., Spotts J.L. and Osmani S.A. (2000). Mitotic histone H3 phosphorylation by the NIMA kinase in Aspergillus nidulans. Cell 102, 293-302.
20. Dhanasekaran D.N., Kashef K., Lee C.M, Xu H. and Reddy E.P. (2007). Scaffold proteins of MAP-kinase modules. Oncogene 26, 3185-3202.
21. Dornan D., Wertz I., Shimizu H., Arnott D., Frantz G.D., Dowd P., O'Rourke K., Koeppen H. and Dixit V.M. (2004). The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429, 86-92.
22. Giot L., Bader J.S., Brouwer C., Chaudhuri A., Kuang B., Li Y., Hao Y.L., Ooi C.E., Godwin B., Vitols E., Vijayadamodar G., Pochart P., Machineni H., Welsh M., Kong Y., Zerhusen B., Malcolm R., Varrone Z., Collis A., Minto M., Burgess S., McDaniel L., Stimpson E., Spriggs F., Williams J., Neurath K., Ioime N., Agee M., Voss E., Furtak K., Renzulli R., Aanensen N., Carrolla S., Bickelhaupt E., Lazovatsky Y., DaSilva A., Zhong J., Stanyon C.A., Finley R.L. Jr., White K.P., Braverman M., Jarvie T., Gold S., Leach M., Knight J., Shimkets R.A., McKenna M.P., Chant J. and Rothberg J.M. (2003). A protein interaction map of Drosophila melanogaster. Science 302, 1727-1736.
23. Gorjánácz M., Klerkx E.P.F., Galy V., Santarella R., Lopez-Iglesias C., Askjaer P. and Mattaj I.W. (2007). Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in post-mitotic nuclear envelope assembly. EMBO J. 26, 132-143.
24. Hanks S.K. and Hunter T. (1995). Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9, 576-596.
25. Haraguchi T., Koujin T., Segura-Totten M., Lee K.K., Matsuoka Y, Yoneda Y., Wilson K.L. and Hiroaka Y. (2001). BAF is required for emerin assembly into the reforming nuclear envelope. J. Cell Sci. 114, 4575-4585.
26. Hsu J.Y., Sun Z.W., Li X., Reuben M., Tatchell K., Bishop D.K., Grushcow J.M., Brame C.J., Caldwell J.A., Hunt D.F., Lin R., Smith M.M. and Allis C.D. (2000). Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 102, 279-291.
27. Ivanovska I. and Orr-Weaver T.L. (2006). Histone modifications and the chromatin scaffold for meiotic chromosome architecture. Cell Cycle 5, 2064-2071.
28. Ivanovska I., Khandan T., Ito T. and Orr-Weaver T.L. (2005). A histone code in meiosis: the histone kinase, NHK-1, is required for proper chromosomal architecture in Drosophila oocytes. Genes Dev. 19, 2571-2582.
29. Kang T.H. and Kim K.T. (2006). Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase. Nat. Cell Biol. 8, 863-869.
30. Kang T.H. and Kim K.T. (2008). VRK3-mediated inactivation of ERK signaling in adult and embryonic rodent tissues. Biochim. Biophys. Acta 1783, 49-58.
31. Kang T.H., Park D.Y., Choi Y.H., Kim K.J., Yoon H.S. and Kim K.T. (2007). Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells. Mol. Cell. Biol. 27, 8533-8546.
32. Kang T.H., Park D.Y., Kim W. and Kim K.T. (2008). VRK1 phosphorylates CREB and mediates CCND1 expression. J. Cell. Sci. 121, 3035-3041.
33. Karnoub A.E. and Weinberg R.A. (2008). Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 9, 517-531.
34. Lancaster O.M., Cullen C.F. and Ohkura H. (2007). NHK-1 phosphorylates BAF to allow karyosome formation in the Drosophila oocyte nucleus. J. Cell Biol. 179, 817-824.
35. Leng R.P., Lin Y., Ma W., Wu H., Lemmers B., Chung S., Parant J.M., Lozano G., Hakem R. and Benchimol S. (2003). Pirh2, p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112, 779-791.
36. Li M., Brooks C.L., Kon N. and Gu W. (2004). A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13, 879-886.
37. Li L.Y., Liu M.Y., Shih H.M., Tsai C.H. and Chen J.Y. (2006). Human cellular protein VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and enhances cell survival. J. Gen. Virol. 87, 2869-2878.
38. López-Borges S. and Lazo P.A. (2000). The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein. Oncogene 19, 3656-3664.
39. Lu B. and Bishop C.E. (2003). Late onset of spermatogenesis and gain of fertility in POG-deficient mice indicate that POG is not necessary for the proliferation of spermatogonia. Biol. Reprod. 69, 161-168.
40. Manning G., Plowman G.D., Hunter T. and Sudarsanam S. (2002). Evolution of protein kinase signaling from yeast to man. Trends Biochem. Sci. 27, 514-520.
41. McKay M.M. and Morrison D.K. (2007). Integrating signals from RTKs to ERK/MAPK. Oncogene 26, 3113-3121.
42. Meek D.W. (1999). Mechanisms of switching on p53: a role for covalent modification? Oncogene 18, 7666-7675.
43. Nezu J., Oku A., Jones M.H. and Shimane M. (1997). Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics 45, 327-331.
44. Nichols R.J. and Traktman P. (2004). Characterization of three paralogous members of the Mammalian vaccinia related kinase family. J. Biol. Chem. 279, 7934-7946.
45. Nichols R.J., Wiebe M.S. and Traktman P. (2006). The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol. Biol. Cell. 17, 2451-2464.
46. Raman M., Chen W. and Cobb M.H. (2007). Differential regulation and properties of MAPKs. Oncogene 26, 3100-3112.
47. Rempel R.E. and Traktman P. (1992). Vaccinia virus B1 kinase: phenotypic analysis of temperature-sensitive mutants and enzymatic characterization of recombinant proteins. J. Virol. 66, 4413-4426.
48. Roy S. and Tenniswood M. (2007). Site specific acetylation of p53 directs selective transcription complex assembly. J. Biol. Chem. 282, 4765-4771.
49. Ryan K.M., Phillips A.C. and Vousden K.H. (2001). Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13, 332-337.
50. Santos C.R., Rodríguez-Pinilla M., Vega F.M., Rodríguez-Peralto J.L., Blanco S., Sevilla A., Valbuena A., Hernández T., van Wijnen A.J., Li F., de Alava E., Sánchez-Céspedes M. and Lazo P.A. (2006). VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma. Mol. Cancer Res. 4, 177-185.
51. Sanz-García M., López-Sánchez I. and Lazo P.A. (2008). Proteomics identification of nuclear Ran GTPase as an inhibitor of human VRK1 and VRK2 (vaccinia-related kinase) activities. Mol. Cell Proteomics 7, 2199-2214.
52. Sevilla A., Santos C.R., Barcia R., Vega F.M. and Lazo P.A. (2004a). c- Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK). Oncogene 23, 8950-8958.
53. Sevilla A., Santos C.R., Vega F.M. and Lazo P.A. (2004b). Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK. J. Biol. Chem. 279, 27458-27465.
54. Stad R., Little N.A., Xirodimas D.P., Frenk R., van der Eb A.J., Lane D.P., Saville M.K. and Jochemsen A.G. (2001). Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep. 2, 1029-1034.
55. Stewart M. (2007). Molecular mechanism of the nuclear protein import cycle. Nat. Rev. Mol. Cell Biol. 8, 195-208.
56. Sternberg, P.W. (2005). Vulval development. WormBook, ed. The C. elegans Research Community, WormBook, doi/10.1895/ wormbook.1.6.1, http://www.wormbook.org.
57. Sundaram M.V. (2006). RTK/Ras/MAPK signaling. WormBook., ed. The C. elegans Research Community, WormBook, doi/10.1895/ wormbook.1.80.1. http://www.wormbook.org.
58. Toledo F. and Wahl G.M. (2006). Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer 6, 909-923.
59. Traktman P., Anderson M.K. and Rempel R.E. (1989). Vaccinia virus encodes an essential gene with strong homology to protein kinases. J. Biol. Chem. 264, 21458-21461.
60. Valbuena A., Vega F.M., Blanco S. and Lazo P.A. (2006). p53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loop. Mol. Cell. Biol. 26, 4782-4793.
61. Valbuena A., López-Sánchez I., Vega F.M., Sevilla A., Sanz-García M., Blanco S. and Lazo P.A. (2007a). Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations. Arch. Biochem. Biophys. 465, 219-226.
62. Valbuena A., Suárez-Gauthier A., López-Rios F., López-Encuentra A., Blanco S., Fernández P.L., Sánchez-Céspedes M. and Lazo P.A. (2007b). Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas. Lung Cancer 58, 303-309.
63. Valbuena A., López-Sánchez I. and Lazo P.A. (2008a). Human VRK1 is an early response gene and its loss causes a block in cell cycle progression. PLoS ONE 3, e1642.
64. Valbuena A., Blanco S., Vega F.M. and Lazo P.A. (2008b). The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53. PLoS ONE 3, e2649.
65. Vega F.M., Gonzalo P., Gaspar M.L. and Lazo P.A. (2003). Expression of the VRK (vaccinia-related kinase) gene family of p53 regulators in murine hematopoietic development. FEBS Lett. 544, 176-180.
66. Vega F.M., Sevilla A. and Lazo P.A. (2004). p53 Stabilization and accumulation induced by human vaccinia-related kinase 1. Mol. Cell. Biol. 24, 10366-10380.
67. Vousden K.H. and Lu X. (2002). Live or let die: the cell's response to p53. Nat. Rev. Cancer 2, 594-604.
68. Wiebe M.S. and Traktman P. (2007). Poxviral B1 kinase overcomes barrier to autointegration factor, a host defense against virus replication. Cell Host Microbe 1, 187-197.
69. Yuan Z.M., Huang Y., Ishiko T., Nakada S., Utsugisawa T., Shioya H., Utsugisawa Y., Yokoyama K., Weichselbaum R., Shi Y. and Kufe D. (1999). Role for p300 in stabilization of p53 in the response to DNA damage. J. Biol. Chem. 274, 1883-1886.
70. Zelko I., Kobayashi R., Honkakoski P. and Negishi M. (1998). Molecular cloning and characterization of a novel nuclear protein kinase in mice. Arch. Biochem. Biophys. 352, 31-36.